The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose
Primary Purpose
Hyperglycemia, Aortic Valve Replacement, Aortic Stenosis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
hyperinsulinemic normoglycemic clamp (HNC)
control group
Sponsored by
About this trial
This is an interventional treatment trial for Hyperglycemia focused on measuring Hyperglycemia, open heart surgery, bypass
Eligibility Criteria
Inclusion Criteria:
- Age 40 - 84 years old, Aortic stenosis, Scheduled for Aortic valve replacement.
Exclusion Criteria:
- Poor quality echocardiographic images unsuitable for analysis
- Off -pump surgical procedure
- Anticipated deep hypothermic circulatory arrest
- Any contraindications to transesophageal echocardiogram (TEE) or other proposed intervention
- Unable to give written informed consent (non-English speaking, vulnerable patients, etc.)
Sites / Locations
- Cleveland Clinic Foundation
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
hyperinsulinemic normoglycemic clamp (HNC)
standard glucose management
Arm Description
Patients will be randomized to receive treatment with HNC during cardiac surgery.
Patients will be randomized to receive treatment with standard glucose management during cardiac surgery.
Outcomes
Primary Outcome Measures
Myocardial Function: Left Ventricular Global Longitudinal Strain (%)
Left ventricular global longitudinal strain measured by intraoperative transesophageal echocardiography at end of surgery and assessed using off-line speckle-tracking echocardiography.
higher values (%) mean a worse outcome.
Intraoperative Left Ventricular (LV) Global Longitudinal Strain Rate
Left ventricular global longitudinal strain rate measured by intraoperative transesophageal echocardiography at end of surgery and assessed using off-line speckle-tracking echocardiography.
higher values mean a worse outcome
Secondary Outcome Measures
Intraoperative Right Ventricular (RV) Systolic Longitudinal Strain
Right ventricular global longitudinal strain measured by intraoperative transesophageal echocardiography at end of surgery and assessed using off-line speckle-tracking echocardiography.
higher values mean a worse outcome.
Intraoperative Right Ventricular (RV) Systolic Longitudinal Strain Rate
Right ventricular global longitudinal strain rate measured by intraoperative transesophageal echocardiography at end of surgery and assessed using off-line speckle-tracking echocardiography.
higher values mean a worse outcome
Full Information
NCT ID
NCT01187329
First Posted
August 19, 2010
Last Updated
October 22, 2018
Sponsor
The Cleveland Clinic
Collaborators
National Institutes of Health (NIH)
1. Study Identification
Unique Protocol Identification Number
NCT01187329
Brief Title
The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose
Official Title
The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose
Study Type
Interventional
2. Study Status
Record Verification Date
October 2018
Overall Recruitment Status
Completed
Study Start Date
October 2010 (undefined)
Primary Completion Date
August 2013 (Actual)
Study Completion Date
December 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The Cleveland Clinic
Collaborators
National Institutes of Health (NIH)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The overall research plan is to test the hypothesis that intraoperative treatment of hyperinsulinemic normoglycemic clamp (HNC) in cardiac surgical patients improves myocardial function and short-term outcomes compared with standard glucose management.
Detailed Description
Specific Aim #1:To determine whether intraoperative use of HNC affords cardioprotective benefits measured by improved echocardiographic measures of myocardial function, serum markers of cardiomyocyte injury, and hemodynamic indices measured immediately (at end of surgery) and during the short-term (initial hospitalization).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperglycemia, Aortic Valve Replacement, Aortic Stenosis, Cardiac Surgery
Keywords
Hyperglycemia, open heart surgery, bypass
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
hyperinsulinemic normoglycemic clamp (HNC)
Arm Type
Experimental
Arm Description
Patients will be randomized to receive treatment with HNC during cardiac surgery.
Arm Title
standard glucose management
Arm Type
Placebo Comparator
Arm Description
Patients will be randomized to receive treatment with standard glucose management during cardiac surgery.
Intervention Type
Other
Intervention Name(s)
hyperinsulinemic normoglycemic clamp (HNC)
Intervention Description
Prior to anesthetic induction, a baseline blood glucose value will be obtained, followed by an insulin infusion of 5 mU.Kg-1.min-1. When blood glucose is <110 mg/dL, a variable continuous infusion of glucose (dextrose 20%) supplemented with potassium (40 mEq/L) and phosphate (30 mmol/L) is administered to preserve normoglycemia (80-110 mg/dL). The glucose infusion is titrated to target glucose levels by checking blood glucose every 5 - 15 min with Accu-Check (Roche Diagnostics, Switzerland) glucose monitor. At sternal closure, insulin infusion is decreased to 1 mU/Kg/min. On admission to the ICU, insulin treatment follows the ICU protocol. The dextrose infusion is slowly weaned off over 2 - 4 hrs maintaining blood glucose > 80 mg/dL. Arterial blood glucose is measured every 30 - 60 min for 2 hrs, then, as stated in ICU protocol.
Intervention Type
Other
Intervention Name(s)
control group
Other Intervention Name(s)
glucose, standard of care
Intervention Description
Baseline arterial blood glucose will be obtained before anesthetic induction. Repeat measurements are performed every 30-90 min. Glucose >150 on CPB will receive insulin according to intraoperative protocol. After surgery, insulin is given according to ICU protocol. Target glucose < 180 mg/dL.
Primary Outcome Measure Information:
Title
Myocardial Function: Left Ventricular Global Longitudinal Strain (%)
Description
Left ventricular global longitudinal strain measured by intraoperative transesophageal echocardiography at end of surgery and assessed using off-line speckle-tracking echocardiography.
higher values (%) mean a worse outcome.
Time Frame
end of surgery (closure), an average of 5 minutes
Title
Intraoperative Left Ventricular (LV) Global Longitudinal Strain Rate
Description
Left ventricular global longitudinal strain rate measured by intraoperative transesophageal echocardiography at end of surgery and assessed using off-line speckle-tracking echocardiography.
higher values mean a worse outcome
Time Frame
end of surgery (closure) an average of 5 minutes
Secondary Outcome Measure Information:
Title
Intraoperative Right Ventricular (RV) Systolic Longitudinal Strain
Description
Right ventricular global longitudinal strain measured by intraoperative transesophageal echocardiography at end of surgery and assessed using off-line speckle-tracking echocardiography.
higher values mean a worse outcome.
Time Frame
end of surgery (closure) an average of 5 minutes
Title
Intraoperative Right Ventricular (RV) Systolic Longitudinal Strain Rate
Description
Right ventricular global longitudinal strain rate measured by intraoperative transesophageal echocardiography at end of surgery and assessed using off-line speckle-tracking echocardiography.
higher values mean a worse outcome
Time Frame
end of surgery (closure) an average of 5 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
84 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 40 - 84 years old, Aortic stenosis, Scheduled for Aortic valve replacement.
Exclusion Criteria:
Poor quality echocardiographic images unsuitable for analysis
Off -pump surgical procedure
Anticipated deep hypothermic circulatory arrest
Any contraindications to transesophageal echocardiogram (TEE) or other proposed intervention
Unable to give written informed consent (non-English speaking, vulnerable patients, etc.)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Andra Duncan, MD
Organizational Affiliation
The Cleveland Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Cleveland Clinic Foundation
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
35848424
Citation
Zhang K, Kumar N, Alfirevic A, Sale S, You J, Bauer A, Duncan AE. Left Ventricular Twist Mechanics Before and After Aortic Valve Replacement: A Feasibility Study and Exploratory Analysis. Semin Cardiothorac Vasc Anesth. 2022 Sep;26(3):226-236. doi: 10.1177/10892532221114791. Epub 2022 Jul 18.
Results Reference
derived
PubMed Identifier
30581109
Citation
Zhang K, Sheu R, Zimmerman NM, Alfirevic A, Sale S, Gillinov AM, Duncan AE. A Comparison of Global Longitudinal, Circumferential, and Radial Strain to Predict Outcomes After Cardiac Surgery. J Cardiothorac Vasc Anesth. 2019 May;33(5):1315-1322. doi: 10.1053/j.jvca.2018.10.031. Epub 2018 Oct 24.
Results Reference
derived
PubMed Identifier
29200066
Citation
Sonny A, Alfirevic A, Sale S, Zimmerman NM, You J, Gillinov AM, Sessler DI, Duncan AE. Reduced Left Ventricular Global Longitudinal Strain Predicts Prolonged Hospitalization: A Cohort Analysis of Patients Having Aortic Valve Replacement Surgery. Anesth Analg. 2018 May;126(5):1484-1493. doi: 10.1213/ANE.0000000000002684.
Results Reference
derived
PubMed Identifier
26702865
Citation
Duncan AE, Sarwar S, Kateby Kashy B, Sonny A, Sale S, Alfirevic A, Yang D, Thomas JD, Gillinov M, Sessler DI. Early Left and Right Ventricular Response to Aortic Valve Replacement. Anesth Analg. 2017 Feb;124(2):406-418. doi: 10.1213/ANE.0000000000001108.
Results Reference
derived
Learn more about this trial
The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose
We'll reach out to this number within 24 hrs